Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 9, 2005, Pages 1395-1400

  Kumar, Dinesh ^a,b   Farrell, Geoffrey C ^a,b   Kench, James ^b   George, Jacob ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Chronic hepatitis; Hepatic steatosis; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; MALE; MORPHOMETRICS; OBESITY; PRECANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; CASE CONTROL STUDY; LIVER TUMOR; MIDDLE AGED; RETROSPECTIVE STUDY; RISK;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK;

EID: 33644660193     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.04007.x     Document Type: Article

References (43)

1. Di Biscglie AM. Hepatitis C and hepatocellular carcinoma. Semin. Liver Dis. 1995 15 : 64 9.
2. Moriya K, Fujie H, Shintani Y et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 1998 4 : 1065 7.
3. Lerat H, Honda M, Beard MR et al. Steatosis and liver cancer in transgenic mice expressing the structural and non-structural proteins of hepatitis C virus. Gastroenterology 2002 122 : 352 65.
4. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res. 2001 61 : 5016 23.
5. Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 2002 36 : 150 5.
6. Ratziu V, Bonyhay L, Di Martino V et al. Survival, liver failure, and hepatocellular carcinoma in obesity related cryptogenic cirrhosis. Hepatology 2002 35 : 1485 93.
7. Bugianesi E, Leone N, Vanni E et al. Expanding the natural history of non-alcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002 123 : 134 40.
8. Shimada M, Hashimoto E, Taniai M et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J. Hepatol. 2002 37 : 154 60.
9. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 2002 36 : 729 36.
10. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001 33 : 1358 64.
11. Hui JM, Kench J, Farrell GC et al. Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection. J. Gastroenterol. Hepatol. 2002 17 : 873 81.
12. Paradis V, Mathurin P, Kollinger M et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J. Clin. Pathol. 1997 50 : 401 6.
13. Moriya K, Nakagawa K, Santa T et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001 61 : 4365 70.
14. Factor M, Kiss AJTW, Woitach JT, Thorgeirsson SS. Disruption of redox homeostasis in the transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. J. Biol. Chem. 1998 273 : 15846 53.
15. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 1996 313 : 17 29.
16. Kumar D, Farrell GC, Fung C, George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response. Hepatology 2002 36 : 1266 72.
17. Hickman IJ, Clouston AD, Macdonald GA et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002 51 : 89 94.
18. Khan MH, Farrell GC, Byth K et al. Which patients with hepatitis C develop liver complications? Hepatology 2000 31 : 513 20.
19. Benvegnu L, Albert A. Risk factors and prevention of hepatocellular carcinoma in HCV infection. Dig. Dis. Sci. 1996 41 : 49S 55S.
20. Silini E, Bottelli R, Asti M et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case control study. Gastroenterology 1996 111 : 199 205.
21. Bruno S, Silini E, Crosignani A et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997 25 : 754 8.
22. Zaman SN, Melia W, Johnson RD, Portmann BC, Johnson PJ, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985 ii : 1357 60.
23. Aizawa Y, Shibamoto Y, Takagi I, Zeniya M, Toda G. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. Cancer 2000 89 : 53 9.
24. Farrell GC. Hepatocellular carcinoma after sustained response to interferon in non-cirrhotic hepatitis C: flaws in the cure, or a clue to the flaws? J. Gastroenterol. Hepatol. 1999 14 : 833 7.
25. Shiratori Y, Imazeki F, Moriyama M et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann. Intern. Med. 2000 132 : 517 24.
26. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 1991 13 : 372 4.
27. Brunt EM, Janney CG, DiBisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999 24 : 2467 74.
28. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999 353 : 1253 7.
29. Ince N, Wands JR. The increasing incidence of hepatocellular carcinoma. N. Engl. J. Med. 1999 340 : 798 9.
30. Ohata K, Hamasaki K, Toriyama K et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003 97 : 3036 43.
31. Hourigan LF, Macdonald GA, Purdie D et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999 29 : 1215 19.
32. Castera L, Hezode C, Roudot-Thoraval F et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003 52 : 288 92.
33. Eckersley RM. Losing the battle of the bulge: causes and consequences of increasing obesity. Med. J. Aust. 2001 174 : 590 2.
34. Cotrim HP, Parana R, Braga E, Lyra L. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? Am. J. Gastroenterol. 2000 95 : 3018 19.
35. Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol. Int. 2001 51 : 127 31.
36. Caldwell SH, Oelsner DH, Lezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999 29 : 664 9.
37. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990 11 : 74 80.
38. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999 116 : 1413 19.
39. Lee RG. Non-alcoholic steatohepatitis: a study of 49 patients. Hum. Pathol. 1989 20 : 594 8.
40. Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am. J. Gastroenterol. 2001 96 : 2957 61.
41. Hassan MM, Hwang L, Hatten CJ et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002 36 : 1206 13.
42. La Vecchia C, Negri F, Decarli A, Franceschi S. Diabetes mellitus and the risk of primary liver cancer. Int. J. Cancer 1997 73 : 204 7.
43. Adami HO, Chow WH, Nyren O et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J. Natl. Cancer Inst. 1996 88 : 1472 7.